Rhumbline Advisers Has $5.19 Million Holdings in Addus HomeCare Co. (NASDAQ:ADUS)

Rhumbline Advisers lifted its stake in shares of Addus HomeCare Co. (NASDAQ:ADUS) by 1.3% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 52,483 shares of the company’s stock after purchasing an additional 649 shares during the period. Rhumbline Advisers’ holdings in Addus HomeCare were worth $5,190,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. Dimensional Fund Advisors LP raised its position in Addus HomeCare by 1.5% in the 4th quarter. Dimensional Fund Advisors LP now owns 692,713 shares of the company’s stock worth $86,833,000 after purchasing an additional 10,434 shares during the last quarter. Capital Research Global Investors acquired a new position in shares of Addus HomeCare during the fourth quarter valued at $51,149,000. TimesSquare Capital Management LLC boosted its holdings in Addus HomeCare by 28.5% in the fourth quarter. TimesSquare Capital Management LLC now owns 355,750 shares of the company’s stock valued at $44,593,000 after acquiring an additional 78,835 shares during the last quarter. Invesco Ltd. boosted its holdings in Addus HomeCare by 6.5% in the fourth quarter. Invesco Ltd. now owns 346,120 shares of the company’s stock valued at $43,386,000 after acquiring an additional 21,266 shares during the last quarter. Finally, Northern Trust Corp increased its position in Addus HomeCare by 3.3% in the fourth quarter. Northern Trust Corp now owns 285,872 shares of the company’s stock worth $35,834,000 after purchasing an additional 9,122 shares during the period. 95.35% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on ADUS. Stephens restated an “overweight” rating and set a $142.00 target price on shares of Addus HomeCare in a research report on Wednesday, March 12th. Macquarie reaffirmed an “outperform” rating and set a $133.00 target price on shares of Addus HomeCare in a report on Tuesday. Wall Street Zen downgraded Addus HomeCare from a “buy” rating to a “hold” rating in a research note on Wednesday, February 26th. Finally, JMP Securities restated a “market outperform” rating and issued a $150.00 price target on shares of Addus HomeCare in a research report on Tuesday, April 22nd. One equities research analyst has rated the stock with a hold rating, six have issued a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat.com, Addus HomeCare presently has an average rating of “Buy” and a consensus price target of $142.57.

Insider Activity

In related news, EVP Michael D. Wattenbarger sold 2,045 shares of the business’s stock in a transaction on Tuesday, May 27th. The shares were sold at an average price of $115.00, for a total value of $235,175.00. Following the sale, the executive vice president now directly owns 7,796 shares of the company’s stock, valued at approximately $896,540. The trade was a 20.78% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 4.60% of the stock is currently owned by company insiders.

Addus HomeCare Stock Up 1.2%

Shares of NASDAQ ADUS opened at $114.03 on Friday. Addus HomeCare Co. has a twelve month low of $88.96 and a twelve month high of $136.72. The company’s fifty day moving average is $107.15 and its 200-day moving average is $112.32. The stock has a market cap of $2.10 billion, a price-to-earnings ratio of 26.09, a P/E/G ratio of 1.41 and a beta of 0.81.

Addus HomeCare (NASDAQ:ADUS) last posted its earnings results on Monday, May 5th. The company reported $1.42 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.33 by $0.09. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The firm had revenue of $337.71 million during the quarter, compared to analysts’ expectations of $341.66 million. During the same period in the previous year, the firm earned $1.21 earnings per share. The company’s revenue was up 20.3% on a year-over-year basis. On average, research analysts anticipate that Addus HomeCare Co. will post 4.59 EPS for the current fiscal year.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.